Criteria | Type of criteria | Source |
---|---|---|
Disease severity | Quantitative | Previous study [7] |
Size of affected population | Quantitative | Previous study [7] |
Unmet needs | Quantitative | Previous study [7] |
Comparative effectiveness | Quantitative | Previous study [7] |
Comparative safety/tolerability | Quantitative | Previous study [7] |
Comparative patients perceived health (PRO) | Quantitative | Previous study [7] |
Type of preventive benefit | Quantitative | Previous study [7] |
Type of therapeutic benefit | Quantitative | Previous study [7] |
Cost of orphan drug | Quantitative | Previous study [7] |
Other medical costs | Quantitative | Previous study [7] |
Non-medical costs | Quantitative | Previous study [7] |
Quality of evidence | Quantitative | Previous study [7] |
Expert consensus / clinical practice guidelines | Quantitative | Previous study [7] |
Population priorities and access | Qualitative | Previous study [7] |
Common goal and specific interests | Qualitative | Previous study [7] |
Opportunity costs and affordability | Qualitative | Previous study [7] |
System capacity and appropriate use of intervention | Qualitative | Previous study [7] |